The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study
Abstract
The associations between colorectal cancer risk and several chronic illnesses, operations and various medications were examined in 715 colorectal cancer cases and 727 age- and sex-matched controls in data derived from a large, comprehensive population-based study of this cancer conducted in Melbourne, Australia. There was a statistically significant deficit among cases of hypertension, heart disease, stroke, chronic chest disease and chronic arthritis and a statistically significant excess of 'haemorrhoids' among cases, and all of these differences were consistent for both colon and rectal cancers and for both males and females. Although no statistically significant differences were found for other cancers, there were twice as many breast cancers among cases (16) than among controls (8) and also there were 9 uterine cancers among cases and only 2 among controls. There was a statistically significant deficit among cases in the use of aspirin-containing medication and vitamin supplements and this was consistent for both colon and rectal cancers and for both males and females. There was a statistically significant excess of large bowel polypectomy among cases. The modelling of these significant associations simultaneously in a logistic regression equation indicated that hypertension, heart disease, chronic arthritis and aspirin use were each independent effects and consistent for both colon and rectal cancers for both males and females and also that these effects were independent of dietary risk factors previously described in the Melbourne study. The possible relevance of these findings towards an understanding of colorectal cancer risk and aetiology is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collett, D., Baker, R. J., & Nelder, J. A. (1979) · Biometrics · doi:10.2307/2530359 · Cited by 645
Alcohol, physical activity and other risk factors for colorectal cancer: A prospective study
Wu, A., Paganini-Hill, A., Ross, R., & Henderson, B. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.140 · Cited by 448
Case‐control study of dietary etiological factors: The Melbourne colorectal cancer study
Kune, S., Kune, G. A., & Watson, L. F. (1987) · Nutrition and Cancer · doi:10.1080/01635588709513908 · Cited by 334
Self-citationJOB ACTIVITY AND COLON CANCER RISK
GARABRANT, D. H., PETERS, J. M., MACK, T. M., & BERNSTEIN, L. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113805 · Cited by 281
The Epidemiology of Large-Bowel Cancer
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60086-x · Cited by 173
Large Bowel Cancer in Women in Relation to Reproductive and Hormonal Factors: A Case-Control Study 2
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.703 · Cited by 172
Incidence of Cancer of the Large Bowel in Women in Relation to Reproductive and Hormonal Factors 2 3
Weiss, N. S., Daling, J. R., & Chow, W. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/67.1.57 · Cited by 131
The Melbourne Colorectal Cancer Study: Incidence Findings by Age, Sex, Site, Migrants and Religion
Kune, S., Kune, G. A., & Watson, L. (1986) · International Journal of Epidemiology · doi:10.1093/ije/15.4.483 · Cited by 89
Self-citationCHOLECYSTECTOMY AND LARGE BOWEL CANCER
Friedman, G. D., Goldhaber, M. K., & Quesenberry, C. P. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92871-6 · Cited by 42
Cited by
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Colorectal Cancer: Molecules and Populations
Potter, J. D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.916 · Cited by 881
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
Popivanova, B. K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., & Mukaida, N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32453 · Cited by 832
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
IARC Handbooks of Cancer Prevention: Breast cancer screening
Feig, S. A. (2003) · Cancer · doi:10.1002/cncr.11334 · Cited by 742
Primary Prevention of Colorectal Cancer
Chan, A. T., & Giovannucci, E. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.057 · Cited by 723
Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J., La Vecchia, C., Meyskens, F., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 714
Aberrant Crypt Foci of the Colon as Precursors of Adenoma and Cancer
Takayama, T., Katsuki, S., Takahashi, Y., Ohi, M., Nojiri, S., Sakamaki, S., Kato, J., Kogawa, K., Miyake, H., & Niitsu, Y. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391803 · Cited by 594
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer
Schoen, R. E., Tangen, C. M., Kuller, L. H., Burke, G. L., Cushman, M., Tracy, R. P., Dobs, A., & Savage, P. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1147 · Cited by 500
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 478
The Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Sheehan, K. M. (1999) · JAMA · doi:10.1001/jama.282.13.1254 · Cited by 461
Aspirin and colorectal cancer: the promise of precision chemoprevention
Drew, D. A., Cao, Y., & Chan, A. T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.4 · Cited by 453
Epidemiology of colorectal cancer
Boyle, P., & Leon, M. E. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.1 · Cited by 437
Burn, J., Sheth, H., Elliott, F., Reed, L., Macrae, F., Mecklin, J.-P., Möslein, G., McRonald, F. E., Bertario, L., Evans, D. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30366-4 · Cited by 431
Prospective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women
Hu, F. B., Manson, J. E., Liu, S., Hunter, D., Colditz, G. A., Michels, K. B., Speizer, F. E., & Giovannucci, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.542 · Cited by 423
Modifiable risk factors for colon cancer
Giovannucci, E. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(02)00057-2 · Cited by 423
Ebrahim, S., & Davey Smith, G. (2008) · Human Genetics · doi:10.1007/s00439-007-0448-6 · Cited by 410
Cao, X., Ding, L., Xie, Z.-Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J.-S. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 408
Benamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., & Chaussade, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00887-4 · Cited by 395
Anti-Inflammatory Drugs as Anticancer Agents
Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R., & Caraglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072605 · Cited by 395
Glycemic index in chronic disease: a review
Augustin, L., Franceschi, S., Jenkins, D., Kendall, C., & La Vecchia, C. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601454 · Cited by 390
Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?
Yuhara, H., Steinmaus, C., Cohen, S. E., Corley, D. A., Tei, Y., & Buffler, P. A. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.301 · Cited by 377
García Rodríguez, L. A., & Huerta-Alvarez, C. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00015 · Cited by 359
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Rostom, A., Dubé, C., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00010 · Cited by 343
Anti-Inflammatory Agents for Cancer Therapy
Rayburn, E. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.05 · Cited by 341
Resolution of inflammation: An organizing principle in biology and medicine
Panigrahy, D., Gilligan, M. M., Serhan, C. N., & Kashfi, K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107879 · Cited by 340
Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
Herschman, H. R., & Hall, W. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666095 · Cited by 335
Expression of cyclooxygenase-2 in prostate carcinoma
Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J., Yoshimura, N., Hla, T., & Wada, S. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<589::aid-cncr14>3.0.co;2-c · Cited by 335
Dubé, C., Rostom, A., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00009 · Cited by 334
Harris, R. E. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-8049-8 · Cited by 329
COX-2: A Target for Colon Cancer Prevention
Marnett, L. J., & DuBois, R. N. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082301.164620 · Cited by 313
DIETARY FACTORS IN HUMAN COLORECTAL CANCER
Lipkin, M., Reddy, B., Newmark, H., & Lamprecht, S. A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.545 · Cited by 305
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Finetti, F., Travelli, C., Ercoli, J., Colombo, G., Buoso, E., & Trabalzini, L. (2020) · Biology · doi:10.3390/biology9120434 · Cited by 302
Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention
Baron, J. A., & Sandler, R. S. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.511 · Cited by 297
Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study
Sturmer, T., Glynn, R. J., Lee, I.-M., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-9-199805010-00003 · Cited by 294
Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer
Levy, G. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068612 · Cited by 290
Aspirin and reduced risk of esophageal carcinoma
Funkhouser, E. M., & Sharp, G. B. (1995) · Cancer · doi:10.1002/1097-0142(19951001)76:7<1116::aid-cncr2820760703>3.0.co;2-i · Cited by 286
Aspirin, salicylates, and cancer
Elwood, P. C., Gallagher, A. M., Duthie, G. G., Mur, L. A., & Morgan, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60243-9 · Cited by 282
Aspirin use, cancer, and polyps of the large bowel
Suh, O., Mettlin, C., & Petrelli, N. J. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d · Cited by 276
Colorectal Cancer: Another Complication of Diabetes Mellitus?
Will, J. C., Galuska, D. A., Vinicor, F., & Calle, E. E. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009534 · Cited by 274
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
Pugh, S., & Thomas, G. A. (1994) · Gut · doi:10.1136/gut.35.5.675 · Cited by 266
Logan, R. F., Little, J., Hawtin, P. G., & Hardcastle, J. D. (1993) · BMJ · doi:10.1136/bmj.307.6899.285 · Cited by 264
Smalley, W., Ray, W. A., Daugherty, J., & Griffin, M. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.161 · Cited by 264
Patrignani, P., & Patrono, C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.083 · Cited by 257
Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention
Chan, T. A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00680-0 · Cited by 255
The Role of Inflammation in Colon Cancer
Janakiram, N. B., & Rao, C. V. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_2 · Cited by 151
Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic
Davis, J. S., Lee, H. Y., Kim, J., Advani, S. M., Peng, H.-L., Banfield, E., Hawk, E. T., Chang, S., & Frazier-Wood, A. C. (2017) · Open Heart · doi:10.1136/openhrt-2016-000550 · Cited by 144
Crawford, S. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00068 · Cited by 108
Chuang, M.-C., Yang, Y.-H., Hsieh, M.-J., Lin, Y.-C., Yang, T.-M., Chen, P.-C., & Hung, M.-S. (2021) · BMC Cancer · doi:10.1186/s12885-021-08999-8 · Cited by 9
“In 1988, a case-control study of 700 patients with colorectal cancer was the first to show that the use of aspirin was beneficial in reducing the risk of cancer [9].”
Background
Metadata
- Authors
- Kune, G. A., Kune, S., & Watson, L. F.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 36
- Issue
- 5
- Pages
- 951-957
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2096851332
- Cited by
- 654
- References
- 9
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.